APEMARS Presale Hits 3.8B+ Tokens — Stage 3 Live; Extreme Upside but High Presale Risk
APEMARS (APRZ) has progressed through its presale rapidly: Stages 1–2 sold out and the project reports over 3.8 billion tokens sold, 350+ holders and roughly $79,347 raised. As of 13 January 2026 the sale entered Stage 3 (“Operation Banana Boost”) at $0.00002448 per token (earlier Stage 2 pricing was $0.00002066). The project advertises a planned listing price of $0.0055, implying a theoretical upside of ~22,367% from the current Stage 3 price (Stage 2 implied ~26,520% from its price). APEMARS promotes staking and referral rewards as token utilities to encourage holding and growth. The coverage contrasts this high-upside, time-sensitive presale with established Layer‑1 networks such as Solana (SOL) and Sui (SUI), noting Solana’s market cap (~$79–80B), price (~$140–$142) and substantial daily volume, and Sui’s smaller but growing market metrics and TVL. Both pieces emphasize that the article is promotional and not investment advice. Key trading takeaways: the presale offers extreme theoretical ROI if the token lists at the advertised price, but presales carry elevated execution, liquidity and regulatory risk; allocations are time-sensitive and can be highly dilutive at listing.
Bullish
The news is bullish for APRZ price prospects in the near term because sellout momentum across early stages, a high advertised listing price and marketing of staking/referral mechanics can drive demand and speculative buying during the presale and immediate listing. Rapid stage sellouts and FOMO typically concentrate buying pressure into the token, creating a short-term upward bias versus a scenario with weak interest. However, this bullish classification applies only to price direction potential relative to the token itself; it does not account for probability of achieving the advertised listing price or post-listing price stability. Significant caveats reduce conviction: presales are high-risk — listed price may not materialize, initial liquidity can be thin or heavily vested/locked, large token allocations to founders/teams or referral payouts can cause immediate dilution, and regulatory or execution failures are common. For traders: short-term trades may benefit from momentum if the token lists and liquidity appears, but risk management is essential (small position sizing, stop-losses, awareness of lockups and tokenomics). Longer-term bullishness is uncertain and depends on execution, real utility/adoption, and token distribution; absent clear fundamentals, the longer-term outlook remains highly speculative.